Product name |
INN / active substance |
Therapeutic area |
Marketing authorisation |
holder |
Hefiya |
Adalimumab |
Ankylosing spondylitis , hidradenitis suppurativa , juvenile rheumatoid arthritis , psoriasis , uveitis |
Sandoz |
26 / 07 / 2018 |
Hyrimoz |
Adalimumab |
Ankylosing spondylitis , Crohn ’ s disease , hidradenitis suppurativa , juvenile rheumatoid arthritis , papulosquamous skin disease , psoriatic arthritis , rheumatoid arthritis , ulcerative colitis , uveitis |
Sandoz |
26 / 07 / 2018 |
Trazimera |
Trastuzumab |
Breast neoplasm , stomach neoplasm |
Pfizer |
26 / 07 / 2018 |
Hulio |
Adalimumab |
Ankylosing spondylitis , Crohn ’ s disease , hidradenitis suppurativa , psoriasis , psoriatic arthritis , rheumatoid arthritis , ulcerative colitis , uveitis |
Mylan / Fujifilm Kyowa Kirin Biologics |
16 / 09 / 2018 |
Pelgraz |
Pegfilgrastim |
Neutropenia |
Accord Healthcare |
21 / 09 / 2018 |
Udenyca |
Pegfilgrastrim |
Neutropenia |
ERA Consulting |
20 / 09 / 2018 |
Ziextenzo |
Pegfilgrastrim |
Neutropenia |
Sandoz |
22 / 11 / 2018 |
Pelmeg |
Pegfilgrastrim |
Neutropenia |
Cinfa Biotech |
20 / 11 / 2018 |
Fulphila |
Pegfilgrastrim |
Neutropenia |
Mylan |
20 / 11 / 2018 |
Ogivri |
Trastuzumab |
Breast neoplasm , stomach neoplasm |
Mylan |
12 / 12 / 2018 |
Zirabev |
Bevacizumab |
Breast neoplasm , colorectal neoplasm , non-small-cell lung carcinoma , renal cell carcinoma , uterine cervical neoplasms |
Pfizer Europe |
12 / 02 / 2019 |
Idacio |
Adalimumab |
Ankylosing spondylitis , Crohn ’ s disease , hidradenitis suppurativa , juvenile rheumatoid arthritis , psoriasis , psoriatic arthritis , rheumatoid arthritis , ulcerative colitis , uveitis |
Fresenius Kabi Deutschland GmbH |
02 / 04 / 2019 |
Grasutek |
Pegfilgrastim |
Neutropenia |
Juta Pharma GmbH |
CHMP positive opinion 20 / 06 / 2019 |